453 related articles for article (PubMed ID: 32787955)
1. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
[TBL] [Abstract][Full Text] [Related]
2. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
3. Heteromers of amyloid precursor protein in cerebrospinal fluid.
Cuchillo-Ibañez I; Lopez-Font I; Boix-Amorós A; Brinkmalm G; Blennow K; Molinuevo JL; Sáez-Valero J
Mol Neurodegener; 2015 Jan; 10():2. PubMed ID: 25573162
[TBL] [Abstract][Full Text] [Related]
4. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
[TBL] [Abstract][Full Text] [Related]
5. Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
Sano Y; Nakaya T; Pedrini S; Takeda S; Iijima-Ando K; Iijima K; Mathews PM; Itohara S; Gandy S; Suzuki T
PLoS One; 2006 Dec; 1(1):e51. PubMed ID: 17183681
[TBL] [Abstract][Full Text] [Related]
6. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
[TBL] [Abstract][Full Text] [Related]
7. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
8. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.
Alexopoulos P; Tsolakidou A; Roselli F; Arnold A; Grimmer T; Westerteicher C; Leante MR; Förstl H; Livrea P; Kurz A; Perneczky R
Alzheimers Dement; 2012 Jul; 8(4):304-11. PubMed ID: 22055653
[TBL] [Abstract][Full Text] [Related]
10. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.
Ho L; Fukuchi Ki; Younkin SG
J Biol Chem; 1996 Nov; 271(48):30929-34. PubMed ID: 8940079
[TBL] [Abstract][Full Text] [Related]
11. sAPPβ and sAPPα increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca
Hesse R; von Einem B; Wagner F; Bott P; Schwanzar D; Jackson RJ; Föhr KJ; Lausser L; Kroker KS; Proepper C; Walther P; Kestler HA; Spires-Jones TL; Boeckers T; Rosenbrock H; von Arnim CAF
Exp Neurol; 2018 Jun; 304():1-13. PubMed ID: 29466703
[TBL] [Abstract][Full Text] [Related]
12. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein receptor LRP3 compromises APP levels.
Cuchillo-Ibañez I; Lennol MP; Escamilla S; Mata-Balaguer T; Valverde-Vozmediano L; Lopez-Font I; Ferrer I; Sáez-Valero J
Alzheimers Res Ther; 2021 Nov; 13(1):181. PubMed ID: 34727970
[TBL] [Abstract][Full Text] [Related]
14. The Absence of Myelin Basic Protein Reduces Non-Amyloidogenic Processing of Amyloid Precursor Protein.
Seiwa C; Sugiyama I; Sugawa M; Murase H; Kudoh C; Asou H
Curr Alzheimer Res; 2021; 18(4):326-334. PubMed ID: 34218780
[TBL] [Abstract][Full Text] [Related]
15. Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.
Cai Z; Liu Z; Xiao M; Wang C; Tian F
Neurochem Res; 2017 Dec; 42(12):3446-3455. PubMed ID: 28836062
[TBL] [Abstract][Full Text] [Related]
16. Acute interleukin-6 modulates key enzymes involved in prefrontal cortex and hippocampal amyloid precursor protein processing.
Marko DM; Finch MS; Yang AJT; Castellani LN; Peppler WT; Wright DC; MacPherson REK
J Appl Physiol (1985); 2023 May; 134(5):1115-1123. PubMed ID: 36892889
[TBL] [Abstract][Full Text] [Related]
17. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease.
Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH
Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328
[TBL] [Abstract][Full Text] [Related]
18. Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.
Wu G; Sankaranarayanan S; Wong J; Tugusheva K; Michener MS; Shi X; Cook JJ; Simon AJ; Savage MJ
J Neurosci Res; 2012 Dec; 90(12):2247-58. PubMed ID: 22987781
[TBL] [Abstract][Full Text] [Related]
19. Effects of phenothiazine-structured compounds on APP processing in Alzheimer's disease cellular model.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2017 Jul; 138():82-89. PubMed ID: 28457944
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
